The hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer

Anticancer Research

Volumn 29, Issue 3, 2009, Pages 871-880

  Kameda, Chizu ^a   Tanaka, Haruo ^a   Yamasaki, Akio ^a   Nakamura, Masafumi ^a   Koga, Kenichiro ^a   Sato, Norihiro ^a   Kubo, Makoto ^a   Kuroki, Syoji ^a   Tanaka, Masao ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Breast cancer; Estrogen receptor negative; Hedgehog signaling pathway; Invasion

Indexed keywords

CYCLOPAMINE; ESTROGEN RECEPTOR ALPHA; PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TUMOR MARKER;

BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ADENOCARCINOMA; AGED; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HEDGEHOG PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VERATRUM ALKALOIDS;

EID: 64949152163     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Cho HS, Ng PA and Katzenellenbogen BS: Differential regulation of gene expression by estrogen in estrogen growth-independent and-dependent MCF-7 human breast cancer cell sublines. Mol Endocrinol 5: 1323-1330, 1991.
2. Platet N, Cathiard AM, Gleizes M and Garcia M: Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51: 55-67, 2004.
3. Dowsett M and Ashworth A: New biology of the oestrogen receptor. Lancet 362: 260-262, 2003.
4. Paone JF, Abeloff MD, Ettinger DS, Arnold EA and Baker RR: The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast. Surg Gynecol Obstet 152: 70-74, 1981.
5. Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 64: 6071-6074, 2004.
6. Ingham PW and McMahon AP: Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15: 3059-3087, 2001.
7. Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR and Frost AR: Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 5: 674-683, 2006.
8. Cohen MM Jr: The hedgehog signaling network. Am J Med Genet A 123: 5-28,2003.
9. Ruel L, Rodriguez R, Gallet A, Lavenant-Staccini L and Therond PP: Stability and association of Smoothened, Costal2 and Fused with Cubitus interruptus are regulated by Hedgehog. Nat Cell Biol 5: 907-913, 2003.
10. Kalderon D: Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol 12: 523-531, 2002.
11. Sasaki H, Nishizaki Y, Hui C, Nakafuku M and Kondoh H: Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development 126: 3915-3924, 1999.
12. Lewis MT: Hedgehog signaling in mouse mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia 6: 53-66,2001.
13. Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, Scott MP and Daniel CW: Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development 126: 5181-5193, 1999.
14. Lee J, Piatt KA, Censullo P and Ruiz i Altaba A: Glil is a target of Sonic hedgehog that induces ventral neural tube development. Development 124: 2537-2552, 1997.
15. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA: Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707-712, 2004.
16. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman, JR, Watkins DN and Beachy PA: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425: 846-851, 2003.
17. Sanchez P, Hernandez AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S and Ruiz i Altaba A: Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 101: 12561-12566, 2004.
18. Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z and Xie J: Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 3: 29, 2004.
19. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA and Baylin SB: Hedgehog signalling within airway epithelial progenitors and in small cell lung cancer. Nature 422: 313-317, 2003.
20. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C, Jimeno A, Gabrielson KL, Matsui W and Maitra A: Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187-2196, 2007.
21. Nagai S, Nakamura M, Yanai K, Wada J, Akiyoshi T, Nakashima H, Ohuchida K, Sato N, Tanaka M and Katano M: Glil contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation. Cancer Sci 99: 1377- 1384, 2008.
22. Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP and Beachy PA: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406: 1005-1009, 2000.
23. Incardona JP, Gaffield W, Kapur RP and Roelink H: The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125: 3553-3562, 1998.